002630 — Orient Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Orient Bio, fiscal year end - March 31st, KRW millions except per share, conversion factor applied.

	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,940	58,244	29,396	35,958	27,265
Net Total Accounts Receivable
Net Total Receivables	9,421	6,676	8,210	13,827	10,057
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29,060	70,498	49,250	58,984	47,415
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31,321	18,319	15,857	17,463	20,516
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	71,519	104,952	81,050	96,988	84,782
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15,230	13,644	3,892	4,207	4,211
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	22,974	21,764	9,658	11,892	12,935
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	48,545	83,188	71,392	85,096	71,847
Total Liabilities & Shareholders' Equity	71,519	104,952	81,050	96,988	84,782
Total Common Shares Outstanding